Crossmark

CaMKK2 Knockout Bone Marrow Cells Collected/Processed in Low Oxygen (Physioxia) Suggests CaMKK2 as a Hematopoietic Stem to Progenitor Differentiation Fate Determinant

Crossref DOI link: https://doi.org/10.1007/s12015-021-10306-8

Published Online: 2022-03-09

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Broxmeyer, Hal E. https://orcid.org/0000-0001-6575-0476
Ropa, James

Capitano, Maegan L.

Cooper, Scott

Racioppi, Luigi

Sankar, Uma
Funding

Funding for this research was provided by:

National Heart, Lung, and Blood Institute (R35 HL139599)

National Institute of Diabetes and Digestive and Kidney Diseases (U54 DK106846)

National Institute of Diabetes and Digestive and Kidney Diseases (T32 DK007519)

National Institutes of Health (2U19AI067798)
License Information

Text and Data Mining valid from 2022-03-09

Version of Record valid from 2022-03-09
More Information

Article History

Accepted: 17 November 2021

First Online: 9 March 2022

Declarations

:

: No problems with ethics approval.

: All authors consented to participate.

: All authors consented to publish this paper.

: No COI from any co-authors.

Document is current

Any future updates will be listed below